Clinical trial
Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and…
NCT00283985 · University Hospital, Limoges, Other · Completed
Key facts
| NCT number | NCT00283985 |
|---|---|
| Title | Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma |
| Official title | Phase II Study of an Association of L-asparaginase-Methotrexate-Dexamethasone for Relapsing and/or Refractory Nasal and Nasal-type NK-T-cell Lymphoma |
| Lead sponsor | University Hospital, Limoges, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin |
| Intervention type | Drug |
| Interventions | Kidrolase, Methotrexate, Dexamethasone, Erwinase |
| Enrollment | 40 |
| Start date | Feb 1, 2006 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2012 |
| First posted | Jan 31, 2006 |
| Last update posted | Feb 28, 2013 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: